INFLIXIMAB DYYB

N/A

Manufactured by Pfizer Laboratories Div Pfizer Inc

142,758 FDA adverse event reports analyzed

Last updated: 2026-04-14

About INFLIXIMAB DYYB

INFLIXIMAB DYYB is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Pfizer Laboratories Div Pfizer Inc. The most commonly reported adverse reactions for INFLIXIMAB DYYB include OFF LABEL USE, CONDITION AGGRAVATED, INTENTIONAL PRODUCT USE ISSUE, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION, ARTHRALGIA. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for INFLIXIMAB DYYB.

Top Adverse Reactions

OFF LABEL USE14,653 reports
CONDITION AGGRAVATED10,493 reports
INTENTIONAL PRODUCT USE ISSUE7,777 reports
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION6,087 reports
ARTHRALGIA4,769 reports
DRUG INEFFECTIVE3,515 reports
FATIGUE3,276 reports
WEIGHT INCREASED2,903 reports
MALAISE2,844 reports
WEIGHT DECREASED2,787 reports
BLOOD PRESSURE INCREASED2,348 reports
HEADACHE2,326 reports
COVID 192,322 reports
NAUSEA2,298 reports
PAIN2,235 reports
BLOOD PRESSURE FLUCTUATION1,941 reports
NASOPHARYNGITIS1,895 reports
THERAPEUTIC RESPONSE SHORTENED1,862 reports
COUGH1,797 reports
PYREXIA1,668 reports
HEART RATE DECREASED1,548 reports
INCORRECT DOSE ADMINISTERED1,532 reports
ABDOMINAL PAIN1,458 reports
DIZZINESS1,440 reports
PRURITUS1,420 reports
DIARRHOEA1,399 reports
DYSPNOEA1,394 reports
VOMITING1,265 reports
DRUG LEVEL DECREASED1,226 reports
OROPHARYNGEAL PAIN1,179 reports
DRUG LEVEL BELOW THERAPEUTIC1,169 reports
RASH1,168 reports
PRODUCT USE ISSUE1,157 reports
ASTHENIA1,144 reports
BACK PAIN1,102 reports
ERYTHEMA1,081 reports
HYPERTENSION1,081 reports
HAEMATOCHEZIA1,078 reports
PAIN IN EXTREMITY1,072 reports
ANAL FISSURE1,018 reports
INFLUENZA1,009 reports
PNEUMONIA909 reports
FISTULA895 reports
ILLNESS894 reports
BLOOD PRESSURE SYSTOLIC INCREASED866 reports
PRODUCT DOSE OMISSION ISSUE856 reports
THERAPEUTIC PRODUCT EFFECT INCOMPLETE839 reports
CROHN^S DISEASE836 reports
NASAL CONGESTION795 reports
POOR VENOUS ACCESS794 reports
HEART RATE INCREASED787 reports
FALL767 reports
CONSTIPATION746 reports
UVEITIS746 reports
APHTHOUS ULCER736 reports
INFECTION716 reports
ABSCESS706 reports
ANXIETY705 reports
RHINORRHOEA705 reports
COLITIS ULCERATIVE701 reports
DRUG LEVEL ABOVE THERAPEUTIC691 reports
STRESS674 reports
HEART RATE IRREGULAR670 reports
ABDOMINAL PAIN UPPER664 reports
URINARY TRACT INFECTION660 reports
ABDOMINAL DISTENSION657 reports
CHILLS655 reports
DRUG SPECIFIC ANTIBODY PRESENT654 reports
SINUSITIS654 reports
OVERDOSE632 reports
FAECAL CALPROTECTIN INCREASED610 reports
DECREASED APPETITE609 reports
CHEST DISCOMFORT597 reports
PERIPHERAL SWELLING596 reports
URTICARIA595 reports
ABDOMINAL DISCOMFORT574 reports
BLOOD PRESSURE DIASTOLIC DECREASED549 reports
CHEST PAIN542 reports
MYALGIA532 reports
MUSCLE SPASMS531 reports
INFUSION RELATED REACTION526 reports
ARTHRITIS519 reports
MUSCULOSKELETAL STIFFNESS510 reports
INSOMNIA503 reports
GAIT DISTURBANCE500 reports
BODY TEMPERATURE DECREASED495 reports
FREQUENT BOWEL MOVEMENTS493 reports
UNEVALUABLE EVENT492 reports
NEPHROLITHIASIS487 reports
INFLAMMATION485 reports
RECTAL HAEMORRHAGE482 reports
JOINT SWELLING478 reports
FEELING ABNORMAL476 reports
MATERNAL EXPOSURE DURING PREGNANCY468 reports
HYPERSENSITIVITY465 reports
C REACTIVE PROTEIN INCREASED464 reports
INTENTIONAL DOSE OMISSION462 reports
MIGRAINE461 reports
FLUSHING459 reports
DEATH452 reports

Report Outcomes

Out of 27,627 classified reports for INFLIXIMAB DYYB:

Serious 82.5%Non-Serious 17.5%

The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.

Demographics Breakdown

Reports by Sex

Female1,810 (59.2%)
Male1,236 (40.5%)
Unknown9 (0.3%)

Reports by Age

Age 5397 reports
Age 4679 reports
Age 4469 reports
Age 5768 reports
Age 5462 reports
Age 6059 reports
Age 5257 reports
Age 6556 reports
Age 3854 reports
Age 6253 reports
Age 5552 reports
Age 5851 reports
Age 5949 reports
Age 2848 reports
Age 3948 reports
Age 5648 reports
Age 6147 reports
Age 3546 reports
Age 4145 reports
Age 4744 reports

Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.

Frequently Asked Questions

How many FDA adverse event reports are associated with INFLIXIMAB DYYB?

This profile reflects 142,758 FDA FAERS reports that mention INFLIXIMAB DYYB. Reporting is voluntary and does not prove that the drug caused any listed event.

Which adverse reactions are most often listed for INFLIXIMAB DYYB?

Frequently reported terms in FAERS include OFF LABEL USE, CONDITION AGGRAVATED, INTENTIONAL PRODUCT USE ISSUE, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION, ARTHRALGIA, DRUG INEFFECTIVE. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.

Who manufactures INFLIXIMAB DYYB?

Labeling and FAERS entries often list Pfizer Laboratories Div Pfizer Inc in connection with INFLIXIMAB DYYB. Always verify the specific product and NDC with your pharmacist.

Important Disclaimer: This content is generated by AI analysis of FDA adverse event reports and is provided for informational purposes only. It is not medical advice. Adverse event reports submitted to the FDA do not prove that a medication caused the reported side effect. Always consult your healthcare provider before starting, stopping, or changing any medication. If you experience a serious side effect, contact your doctor or call 911 immediately.